Piper Sandler Reiterates Overweight on Nyxoah, Lowers Price Target to $6

Benzinga Newsdesk www.benzinga.com Negative 92.9%

Neg 92.9% Neu 0% Pos 0%

Piper Sandler analyst Adam Maeder reiterates Nyxoah (NASDAQ:NYXH) with a Overweight and lowers the price target from $7 to $6.